pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4540 |
Genomic Coordinates | chr9: 36864254 - 36864308 |
Description | Homo sapiens miR-4540 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4540 | |||||||||
Sequence | 35| UUAGUCCUGCCUGUAGGUUUA |55 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Illumina | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RSRC2 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | arginine and serine rich coiled-coil 2 | ||||||||||||||||||||
Transcript | NM_023012 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RSRC2 | |||||||||||||||||||||
3'UTR of RSRC2 (miRNA target sites are highlighted) |
>RSRC2|NM_023012|3'UTR 1 AAATGATCACACTTGTAAAGTTTGGGACTTATAGACTTCTTGTTCTGATGTCACGTCCTTGTTCACCAAACAGCTAGCAC 81 TCTAGCTTGCATGGGTGTTGCATTGACTTTAATTTATTGAAAAATACAAATTTTTGTAAATATCAGATCAGTGATACTGG 161 TGTTAGTGTTGTAATCAGGTTAAACCCACTTCCATTAAACTTGACAGGACTATAGAAGGATAATATTTTTTAGTTCATGA 241 ATTCTACTTTTCAAATATATAAAAGCTGCAGGTGGGGATAAAATCTCATACATGGATTTTTTCGTGTCCGCTGTCTTGTG 321 TACTTTTGTACTTAACCTTGTACAGTTATTTTCATCTCTTGAAACATGAAAGAAATGTTATGTAGATGTTCTTTAGAAGA 401 TCTGGCCATTTGGTACATAATCCAGCACAGATAAGCTGGGTGGTAATGATAATAAAAATGGTTTTCTCAAAACTGGTGTT 481 AATTTAAGTTACCTGGGATGTTTCTTTGAATTTGTTTTATAGTTTCTGTAGCATTTGGCAATTGCTGTTAGAAAACACTA 561 GCTAGAAATCCCCTCCCCACCACCCTTTTTAAGGCCAGTTAACTATACTACAGTCAATACCGTGGTGAGCAAAAATGTAA 641 AAGGTGGAAGGAGAAAACTTACTAAAATAGTATGTTTTCCTATTATAAGGGACAGACTTGGTATTCAGTATTTGTCAAAT 721 ATTACATGTGTTATTCAGGAGATAGATTAATGCATTAAAGGGATGTAAGCACTTTTATTTTAATAAAGTGCCTTATAACA 801 AGTTCTTTGCATGCTTTTTGCTCATTATCCCTTTGAAGTCTTCTCCAGCATAGACTATAAAATATTAAAATATTAGAAAT 881 TTTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 65117.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000331738.7 | 3UTR | UUAAACCCACUUCCAUUAAACUUGACAGGACUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000331738.7 | 3UTR | UUAAACCCACUUCCAUUAAACUUGACAGGACUAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000331738.7 | 3UTR | UUAAACCCACUUCCAUUAAACUUGACAGGACUAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
29 hsa-miR-4540 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT154897 | GNAS | GNAS complex locus | 2 | 2 | ||||||||
MIRT444915 | PSG11 | pregnancy specific beta-1-glycoprotein 11 | 2 | 2 | ||||||||
MIRT446718 | PSG3 | pregnancy specific beta-1-glycoprotein 3 | 2 | 2 | ||||||||
MIRT464587 | UBN2 | ubinuclein 2 | 2 | 2 | ||||||||
MIRT468816 | RSRC2 | arginine and serine rich coiled-coil 2 | 2 | 6 | ||||||||
MIRT469397 | REL | REL proto-oncogene, NF-kB subunit | 2 | 6 | ||||||||
MIRT491901 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 2 | 2 | ||||||||
MIRT498959 | ORC4 | origin recognition complex subunit 4 | 2 | 8 | ||||||||
MIRT499438 | ODF2L | outer dense fiber of sperm tails 2 like | 2 | 8 | ||||||||
MIRT506234 | PEX13 | peroxisomal biogenesis factor 13 | 2 | 4 | ||||||||
MIRT527911 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT532624 | PHF5A | PHD finger protein 5A | 2 | 2 | ||||||||
MIRT538103 | DDX6 | DEAD-box helicase 6 | 2 | 2 | ||||||||
MIRT549032 | CASZ1 | castor zinc finger 1 | 2 | 2 | ||||||||
MIRT559870 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT575888 | Ablim1 | actin-binding LIM protein 1 | 2 | 4 | ||||||||
MIRT608663 | ABLIM1 | actin binding LIM protein 1 | 2 | 5 | ||||||||
MIRT616515 | C9orf170 | chromosome 9 open reading frame 170 | 2 | 2 | ||||||||
MIRT624063 | EID1 | EP300 interacting inhibitor of differentiation 1 | 2 | 2 | ||||||||
MIRT625533 | RALGAPB | Ral GTPase activating protein non-catalytic beta subunit | 2 | 2 | ||||||||
MIRT637169 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT639274 | KLHL23 | kelch like family member 23 | 2 | 2 | ||||||||
MIRT642924 | CCDC90B | coiled-coil domain containing 90B | 2 | 2 | ||||||||
MIRT649085 | FBXO25 | F-box protein 25 | 2 | 2 | ||||||||
MIRT655089 | PI4K2A | phosphatidylinositol 4-kinase type 2 alpha | 2 | 2 | ||||||||
MIRT700888 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT705966 | ACBD5 | acyl-CoA binding domain containing 5 | 2 | 2 | ||||||||
MIRT709418 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT723921 | ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif 15 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|